Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
Clinical trial NCT02558959 · COMPLETED
Trial details
- NCT number
- NCT02558959
- Sponsor
- Zhejiang University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-09-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.